Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000695654 | SCV000824166 | uncertain significance | Facioscapulohumeral muscular dystrophy 2 | 2018-05-07 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with SMCHD1-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with phenylalanine at codon 1050 of the SMCHD1 protein (p.Ile1050Phe). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and phenylalanine. |
Revvity Omics, |
RCV003489818 | SCV004237613 | uncertain significance | not provided | 2023-05-03 | criteria provided, single submitter | clinical testing |